We use cookies to improve your experience, analyze site usage, and show relevant ads. Go to our Privacy Policy for details.
The call conveyed a predominantly positive operational and financial tone: a meaningful sequential EBITDA recovery (to $615M), strong cash/liquidity and cash‑conversion (111%), significant portfolio progress (sale of four European assets), trade working capital and fixed cost reductions, and clear commercial tailwinds from tighter global supply that favor LYB's U.S./European cost advantaged assets. Offsetting negatives include operational outages (Bayport, La Porte) that trimmed Q1 results, softness in technology licensing, a 50% dividend cut to preserve flexibility, and persistent geopolitical/input‑cost risks that could pressure margins or demand in future quarters. On balance, the highlights around improved earnings, cash conversion, portfolio restructuring and market positioning materially outweigh the lowlights, though uncertainty remains from outages and geopolitical risk.
Guidance highlights: management is targeting $500 million of incremental cash flow in 2026 (bringing the cumulative total since 2025 to $1.3 billion), while maintaining capital discipline (Q1 capex $269 million; Q1 operating cash use $269 million), a cash balance of $2.6 billion and available liquidity of $7.3 billion; over the past 12 months EBITDA converted to cash at 111% (versus an 80% target) and trade working capital was $450 million lower year‑over‑year on March 31, though the company expects an intentional working‑capital build in Q2 to capture market opportunities. Financial and tax guidance includes an expected 2026 effective and cash tax rate of 15%–20%, a Board‑approved 50% cut to the quarterly dividend (Q1 shareholder returns $224 million), and continued focus on preserving an investment‑grade balance sheet and prefunded debt maturities. Operationally, company Q1 results were $0.49 EPS and $615 million EBITDA, with O&P‑Americas Q1 EBITDA $327 million, segment operating rate ~85% (crackers ~95%) and a Q2 nameplate utilization target of ~90%; O&P pricing actions include a cumulative $0.50/lb polyethylene increase across April/May and $0.10/lb polypropylene spread increases in both months, April PE orders ~20% above pre‑war averages, NA PE industry sales +6.5% YoY and inventories down 7.6%. I&D posted Q1 EBITDA $224 million, is targeting ~75% utilization in Q2, and expects the Bayport PO/TBA outage (which reduced Q1 EBITDA by ~$40 million) to restart toward end‑Q2 (outage cost ~ $25 million/week while down); the company expects future growth projects (Channelview/Hyperzone/acetyls debottlenecks and MoReTec‑1) to deliver roughly $400 million of incremental EBITDA (MoReTec‑1 ramping toward end of 2027). Additional structural actions: Q1 fixed costs were about $50 million lower versus Q1 2025, headcount has been reduced ~3,000 positions (~15%) since end‑2024, and Technology and APS are expected to see improving near‑term results (Tech Q2 roughly in line with Q4‑2025; APS improving but facing contractual pricing lags).
Q1 diluted EPS $0.49 and EBITDA $615 million (EBITDA improved nearly 50% sequentially), cash balance $2.6 billion and total liquidity $7.3 billion. Twelve‑month EBITDA-to-cash conversion was 111% vs the long‑term target of 80%.
O&P‑Americas EBITDA $327 million — roughly double the prior quarter (≈100% sequential increase). Segment ran at ~85% (crackers ~95%) in Q1 and company expects ~90% nameplate utilization in Q2. North American PE industry sales +6.5% YoY and inventories -7.6%; April PE orders ~20% above pre‑war averages. Company announced cumulative PE price increases of $0.50/lb for April–May and PP spread increases of $0.10/lb.
I&D EBITDA rose sequentially to $224 million driven by stronger volumes and improved margins (methanol prices ~doubled from ~$300 to ~$600/ton over three months; VAM and acid prices materially higher). Company noted PO/TBA and POSM technologies are first‑quartile cost positions and expects improved oxyfuels and acetyls margins in Q2 as seasonal demand tightens supply.
Completed sale of four European assets as a milestone in portfolio transformation. Since end of 2024 headcount reduced by ~3,000 positions (~15%). Management targets $500 million incremental cash flow in 2026 (bringing cumulative improvement since 2025 to $1.3 billion). Company expects ~€110 million/year CapEx reduction and ~€400 million/year fixed cost reduction from the transaction scope.
Trade working capital was $450 million lower on March 31 vs. a year ago. First‑quarter fixed costs were already more than $50 million below Q1 2025. Value enhancement program (VEP) and reliability projects (Channelview above benchmark, Hyperzone and acetyls debottlenecks) underpin further margin/cash upside; planned growth projects (e.g., MoReTec‑1) expected to add ~ $400 million EBITDA on ramp.
Ongoing Middle East conflict has tightened global supply (company estimates >20% of global ethylene/PE/PP capacity impacted), benefiting cost‑advantaged U.S. ethane producers. LYB notes 90% of its PE capacity and ~70% of PP capacity are in North America/Europe, positioning the company to fill export and local supply deficits.
Hello, and welcome to the LyondellBasell Teleconference. At the request of LyondellBasell, this conference is being recorded for instant replay purposes. [Operator Instructions] I would now like to turn the call over to Mr. David Kinney, Head of Investor Relations. Sir, you may begin.
Thank you, operator, and welcome everyone to today's call. Before we begin the discussion, I would like to point out that a slide presentation accompanies the call and is available on our website at investors.lyondellbasell.com. Today, we will be discussing our first quarter results, while making reference to some forward-looking statements and non-GAAP financial measures. We believe the forward-looking statements are based upon reasonable assumptions and the alternative measures are useful to investors. Nonetheless, the forward-looking statements are subject to significant risk and uncertainty. We encourage you to learn more about the factors that could lead our actual results to differ by reviewing the cautionary statements in the presentation slides and our regulatory filings, which are also available on our Investor Relations website. Comments made on this call will be in regard to our underlying business results using non-GAAP financial measures, such as EBITDA and earnings per share, excluding identified items. Additional documents on our Investor website provide reconciliations of non-GAAP financial measures to GAAP financial measures, together with other disclosures, including the earnings release and our business results discussion.
A recording of this call will be available by teleph...